School

The University of Sydney School of Pharmacy

PEOPLE

    • Pharmacy Professional Practitioner
    • Faculty of Medicine and Health
    • Pharmacy Professional PractitionerFaculty of Medicine and Health

    Dr Arwa Abu Sardaneh is a Pharmacy Practitioner and Lecturer jointly based at the University of Sydney and Westmead Hospital. She is the Bachelor of Pharmacy (Hons) and Master of Pharmacy clinical placement coordinator at Westmead Hospital. She received a Bachelor of Pharmacy (Honours) and a PhD in Pharmacy from the University of Sydney. She worked as a clinical pharmacist at Royal Prince Alfred Hospital and specialised in critical care. At Royal Prince Alfred Hospital, Arwa developed her skills as a clinician researcher and educator. She received the Advanced Pharmacy Australia fellowship in 2024 highlighting her leadership and significant academic and professional contributions to Australian hospital pharmacy.

    Dr Arwa Abu Sardaneh is a Pharmacy Practitioner and Lecturer jointly based at the University of Sydney and Westmead Hospital. She is the Bachelor of Pharmacy (Hons) and Master of Pharmacy clinical placement coordinator at Westmead Hospital. She received a Bachelor of Pharmacy (Honours) and a PhD in Pharmacy from the University of Sydney. She worked as a clinical pharmacist at Royal Prince Alfred Hospital and specialised in critical care. At Royal Prince Alfred Hospital, Arwa developed her skills as a clinician researcher and educator. She received the Advanced Pharmacy Australia fellowship in 2024 highlighting her leadership and significant academic and professional contributions to Australian hospital pharmacy.

    • Sydney Pharmacy School
    • Associate Lecturer​
    • Faculty of Medicine and Health
    • Associate Lecturer​Faculty of Medicine and Health

    Shoohb Alassadi is a registered pharmacist and Associate Lecturer at the University of Sydney. She graduated with a Bachelor of Pharmacy from the University of Sydney in 2021 and has since focused on integrating Pharmaceutical Sciences with Pharmacy Practice. Shoohb has also gained valuable experience as a Public Health Officer, which provided her with insights into health systems and policy.Currently, Shoohb is completing her Master of Philosophy (MPhil) and teaches in the Pharmaceutical Science and Pharmacy Practice units. Her teaching approach emphasises the application of scientific knowledge in practical pharmacy settings, preparing students for their future roles as healthcare professionals.

    Shoohb Alassadi is a registered pharmacist and Associate Lecturer at the University of Sydney. She graduated with a Bachelor of Pharmacy from the University of Sydney in 2021 and has since focused on integrating Pharmaceutical Sciences with Pharmacy Practice. Shoohb has also gained valuable experience as a Public Health Officer, which provided her with insights into health systems and policy.Currently, Shoohb is completing her Master of Philosophy (MPhil) and teaches in the Pharmaceutical Science and Pharmacy Practice units. Her teaching approach emphasises the application of scientific knowledge in practical pharmacy settings, preparing students for their future roles as healthcare professionals.

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Pharmacology and pharmaceutical sciences
    • Chair of Clinical Pharmacy (Westmead)
    • Faculty of Medicine and Health
    • Chair of Clinical Pharmacy (Westmead)Faculty of Medicine and Health

    Professor Jan-Willem Alffenaar is a hospital pharmacist and clinical pharmacologist and Chair of Clinical Pharmacy at the University of Sydney Pharmacy School and Westmead Hospital. He is theme lead ‘Antimicrobial resistance and novel therapies’ at the University of Sydney Infectious Diseases Institute (Sydney ID) and member of the Antimicrobial Stewardship Committee, the Drug Committee, Chair of the Scientific Advisory Committee and member of the Human Ethics Research Committee at Westmead Hospital. He is an internationally recognized expert in therapeutic drug monitoring and dose optimization of antimicrobial therapy. He is the Past President of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. He is a member of the WHO’s Technical Advisory Group on TB drug dosing. Professor Alffenaar led systematic reviews for WHO on various antimicrobial drugs informing the WHO TB treatment policy review meeting as well as the WHO Fungal Priority Pathogen List. His research is focussed on personalized dosing in routine care using innovative sampling techniques such as dried blood spot and point-of-care saliva testing.

    Professor Jan-Willem Alffenaar is a hospital pharmacist and clinical pharmacologist and Chair of Clinical Pharmacy at the University of Sydney Pharmacy School and Westmead Hospital. He is theme lead ‘Antimicrobial resistance and novel therapies’ at the University of Sydney Infectious Diseases Institute (Sydney ID) and member of the Antimicrobial Stewardship Committee, the Drug Committee, Chair of the Scientific Advisory Committee and member of the Human Ethics Research Committee at Westmead Hospital. He is an internationally recognized expert in therapeutic drug monitoring and dose optimization of antimicrobial therapy. He is the Past President of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. He is a member of the WHO’s Technical Advisory Group on TB drug dosing. Professor Alffenaar led systematic reviews for WHO on various antimicrobial drugs informing the WHO TB treatment policy review meeting as well as the WHO Fungal Priority Pathogen List. His research is focussed on personalized dosing in routine care using innovative sampling techniques such as dried blood spot and point-of-care saliva testing.

    • Sydney Pharmacy School
    • Conference as a panellist or speaker
    • Career advice
    • Industry projects
    • Membership of an advisory committee
    • Mentoring
    • Research collaboration
    • Research supervision
    Fields of Research (2020)
    • Infectious diseases
    • Clinical pharmacy and pharmacy practice
    • Pharmacology and pharmaceutical sciences
    • Level 3 Supervisor
    • Faculty of Medicine and Health
    • Level 3 SupervisorFaculty of Medicine and Health

     

    Dr Megan G Anakin, BSc (McGill), BFA (NSCAD), BEd (Dalhousie), MEd (Simon Fraser), PhD (Otago), FAMEE, FAMEE, SFHEA, Senior Lecturer in Pharmacy Education, The University of Sydney School of Pharmacy, Sydney, NSW, Australia. ORCID.

     

    Dr Megan G Anakin, BSc (McGill), BFA (NSCAD), BEd (Dalhousie), MEd (Simon Fraser), PhD (Otago), FAMEE, FAMEE, SFHEA, Senior Lecturer in Pharmacy Education, The University of Sydney School of Pharmacy, Sydney, NSW, Australia. ORCID.

    • Sydney Pharmacy School
    • Research collaboration
    • Research supervision
    • Mentoring
    • Conference as a panellist or speaker
    • Academics can be contacted directly or via media.office@sydney.edu.au
    • 4 Quality Education
    • 3 Good Health and Well Being
    Fields of Research (2020)
    • Other education not elsewhere classified
    • Professor
    • Faculty of Medicine and Health
    • ProfessorFaculty of Medicine and Health

    Prof Jonathon Arnold is Director of Preclinical Research and Deputy Academic Director at the Lambert Initiative for Cannabinoid Therapeutics, which specialises in the discovery and development of cannabis-based medicines. Jonathon has published over 150 research papers (h-index = 53) and reports on cannabis and the cannabinoids. He currently leads various projects which examine the efficacy of cannabinoids in preclinical models of disease including epilepsy, sleep and ageing. In addition, his research explores the role of the endogenous cannabinoid system in various diseases. He has provided expert advice on cannabis and the cannabinoids to the ACT Legislative Assembly, Food Standards Australia New Zealand (FSANZ) and the World Health Organisation (WHO).

    Also see http://sydney.edu.au/science/lambert/

    Prof Jonathon Arnold is Director of Preclinical Research and Deputy Academic Director at the Lambert Initiative for Cannabinoid Therapeutics, which specialises in the discovery and development of cannabis-based medicines. Jonathon has published over 150 research papers (h-index = 53) and reports on cannabis and the cannabinoids. He currently leads various projects which examine the efficacy of cannabinoids in preclinical models of disease including epilepsy, sleep and ageing. In addition, his research explores the role of the endogenous cannabinoid system in various diseases. He has provided expert advice on cannabis and the cannabinoids to the ACT Legislative Assembly, Food Standards Australia New Zealand (FSANZ) and the World Health Organisation (WHO).

    Also see http://sydney.edu.au/science/lambert/

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Clinical pharmacology and therapeutics
    • Pharmacology and pharmaceutical sciences
    • Professor in Medicines Use Optimisation
    • Faculty of Medicine and Health
    • Professor in Medicines Use OptimisationFaculty of Medicine and Health

    BPharm(Hons) MSc PhD G Cert Ed Stud (Higher Ed), MPS MRPharmS, FFIP

    Professor Parisa Aslani, PhD, BPharm(Hons), MSc, G Cert Ed Stud (Higher Ed), is the Professor in Medicines Use Optimisation at the School of Pharmacy, The University of Sydney.

     

    Professor Parisa Aslani holds a BPharm(Hons) (1990) from Kings College (University of London); MSc (in Pharmaceutics; 1995), PhD (in Pharmacy Practice; 2000) and Grad Cert Ed Stud (Higher Ed) (2001) from the University of Sydney. She has worked as a community pharmacist in the UK and Australia.

     

    Professor Aslani has been a researcher and educator in the field of consumer medicine information and adherence for the past 25 years. She has received the University of Sydney’s prestigious Thompson Equity Fellowship (2013), which recognizes research excellence and aims to promote and enhance the career of academic women. She was awarded the Royal Pharmaceutical Society (UK) Pharmacy Research UK Award 2013, in recognition of a significant contribution to the field of pharmacy research.

     

    She is a registered pharmacist in Australia and the UK. Prof Aslani is Honorary Professor in the School of Healthcare, Faculty of Medicine & Health, University of Leeds; and Academic Advisor to Luto Research Limited, UK (which develops healthcare material for consumers in partnership with consumers). She is a fellow of the International Pharmaceutical Federation (FIP), and immediate past FIP Vice President (2020-2024), and Immediate Past President of the Health and Medicines Information Section. She was Chair of the 81st FIP World Pharmacy and Pharmaceutical Sciences Congress 2023 held in Brisbane, Australia. She is also a Fellow of the Pharmaceutical Society of Australia, and a Foundation Fellow of the Australian and New Zealand College of Advanced Pharmacy. During her employment she has held a number of significant leadership roles within the University, and externally in the profession, and has had a number of career breaks. She has just completed a 5-year term as Deputy Head and Director of Academic Career Development at the School of Pharmacy, The University of Sydney.

     

    Prof Aslani has published over 190 research articles in peer-review journals; 7 books and 11 book chapters; 4455 citations of her articles since 2020 (career total: 9410); h-index of 52 (Google Scholar). She has been a CI on 46, and AI on 2 grants (total over $7 million). Key research funding include a competitive tender (2008) in the area of Consumer Medicine Information (CMI) from the Commonwealth Department of Health and Ageing managed through the Pharmacy Guild of Australia; a recent (2017-2019) NHMRC grant on Question Prompt Lists for parents and carers of children with ADHD; a recent (2020-2024) NHMRC Partnership Project on Community Health workers Extending Care in the Community; and an Australian Government Department of Health and Aged Care tendered project on the Dose Administration Aid (DAA) program to evaluate current program and provide recommendations for future directions.

    BPharm(Hons) MSc PhD G Cert Ed Stud (Higher Ed), MPS MRPharmS, FFIP

    Professor Parisa Aslani, PhD, BPharm(Hons), MSc, G Cert Ed Stud (Higher Ed), is the Professor in Medicines Use Optimisation at the School of Pharmacy, The University of Sydney.

     

    Professor Parisa Aslani holds a BPharm(Hons) (1990) from Kings College (University of London); MSc (in Pharmaceutics; 1995), PhD (in Pharmacy Practice; 2000) and Grad Cert Ed Stud (Higher Ed) (2001) from the University of Sydney. She has worked as a community pharmacist in the UK and Australia.

     

    Professor Aslani has been a researcher and educator in the field of consumer medicine information and adherence for the past 25 years. She has received the University of Sydney’s prestigious Thompson Equity Fellowship (2013), which recognizes research excellence and aims to promote and enhance the career of academic women. She was awarded the Royal Pharmaceutical Society (UK) Pharmacy Research UK Award 2013, in recognition of a significant contribution to the field of pharmacy research.

     

    She is a registered pharmacist in Australia and the UK. Prof Aslani is Honorary Professor in the School of Healthcare, Faculty of Medicine & Health, University of Leeds; and Academic Advisor to Luto Research Limited, UK (which develops healthcare material for consumers in partnership with consumers). She is a fellow of the International Pharmaceutical Federation (FIP), and immediate past FIP Vice President (2020-2024), and Immediate Past President of the Health and Medicines Information Section. She was Chair of the 81st FIP World Pharmacy and Pharmaceutical Sciences Congress 2023 held in Brisbane, Australia. She is also a Fellow of the Pharmaceutical Society of Australia, and a Foundation Fellow of the Australian and New Zealand College of Advanced Pharmacy. During her employment she has held a number of significant leadership roles within the University, and externally in the profession, and has had a number of career breaks. She has just completed a 5-year term as Deputy Head and Director of Academic Career Development at the School of Pharmacy, The University of Sydney.

     

    Prof Aslani has published over 190 research articles in peer-review journals; 7 books and 11 book chapters; 4455 citations of her articles since 2020 (career total: 9410); h-index of 52 (Google Scholar). She has been a CI on 46, and AI on 2 grants (total over $7 million). Key research funding include a competitive tender (2008) in the area of Consumer Medicine Information (CMI) from the Commonwealth Department of Health and Ageing managed through the Pharmacy Guild of Australia; a recent (2017-2019) NHMRC grant on Question Prompt Lists for parents and carers of children with ADHD; a recent (2020-2024) NHMRC Partnership Project on Community Health workers Extending Care in the Community; and an Australian Government Department of Health and Aged Care tendered project on the Dose Administration Aid (DAA) program to evaluate current program and provide recommendations for future directions.

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Clinical pharmacy and pharmacy practice
    • Clinical pharmacology and therapeutics
    • Health counselling
    • Pharmacology and pharmaceutical sciences
    • Health services and systems
    • Social determinants of health
    • Public health
    • Health promotion
    • Health management
    • Head of Pharmacology (L2 Supervisor)
    • Faculty of Medicine and Health
    • Head of Pharmacology (L2 Supervisor)Faculty of Medicine and Health

    Professor Bagley is an academic in Sydney Pharmacy School within the Faculty of Medicine and Health.

    Professor Bagley completed a PhD at The University of Sydney in 2001. She was a C.J Martin Fellow from 2001 to 2006. During this time she was a postdoctoral fellow in the laboratory of Professor Gary Westbrook at the Vollum Institute (Oregon, USA) and at the Pain Management Research Institute (University of Sydney).

    Professor Bagley's established her reserach laboratory in the Brain and Mind Institute (2010-2011), moved to Pharmacology in 2011 and Sydney Pharmacy School in 2021 and has a laboratory in the Charles Perkins Centre.

    Professor Bagley is an academic in Sydney Pharmacy School within the Faculty of Medicine and Health.

    Professor Bagley completed a PhD at The University of Sydney in 2001. She was a C.J Martin Fellow from 2001 to 2006. During this time she was a postdoctoral fellow in the laboratory of Professor Gary Westbrook at the Vollum Institute (Oregon, USA) and at the Pain Management Research Institute (University of Sydney).

    Professor Bagley's established her reserach laboratory in the Brain and Mind Institute (2010-2011), moved to Pharmacology in 2011 and Sydney Pharmacy School in 2021 and has a laboratory in the Charles Perkins Centre.

    • Sydney Pharmacy School
    • Research supervision
    • Academics can be contacted directly or via media.office@sydney.edu.au
    Fields of Research (2020)
    • Basic pharmacology
    • Central nervous system
    • Medical biochemistry - amino acids and metabolites
    • Neurosciences
    • Pharmacology and pharmaceutical sciences
    • Professor
    • Faculty of Medicine and Health
    • ProfessorFaculty of Medicine and Health
    MSc Eng, PhD

    Associate Professor Thomas Balle was previously employed as an Associate Professor at the University of Copenhagen, Denmark where he was a project leader of the Cys-loop receptor project which takes a structural approach to ligand gated ion channel drug discovery. His most recent work includes establishing a pipeline for crystallisation and structure determination of acetylcholine binding proteins as structural surrogates for nicotinic acetylcholine a4b2 receptors and establishment of a computational chemistry platform being used in collaboration with academic and biotech collaborators in discovery projects identifying novel modulators of ligand gated ion channels.

    Thomas originally trained as medicinal chemist and did his PhD in an industrial setting at the Danish pharmaceutical company H. Lundbeck A/S. Here Thomas was involved in design and synthesis of CNS drugs and in particular in identification and development of biomarkers for noninvasive brain imaging using positron emission tomography.

    MSc Eng, PhD

    Associate Professor Thomas Balle was previously employed as an Associate Professor at the University of Copenhagen, Denmark where he was a project leader of the Cys-loop receptor project which takes a structural approach to ligand gated ion channel drug discovery. His most recent work includes establishing a pipeline for crystallisation and structure determination of acetylcholine binding proteins as structural surrogates for nicotinic acetylcholine a4b2 receptors and establishment of a computational chemistry platform being used in collaboration with academic and biotech collaborators in discovery projects identifying novel modulators of ligand gated ion channels.

    Thomas originally trained as medicinal chemist and did his PhD in an industrial setting at the Danish pharmaceutical company H. Lundbeck A/S. Here Thomas was involved in design and synthesis of CNS drugs and in particular in identification and development of biomarkers for noninvasive brain imaging using positron emission tomography.

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Receptors and membrane biology
    • Basic pharmacology
    • Pharmacology and pharmaceutical sciences
    • Biologically active molecules
    • Biochemistry and cell biology
    • Medical biotechnology
    • Medical biochemistry and metabolomics
    • Lecturer
    • Faculty of Medicine and Health
    • LecturerFaculty of Medicine and Health
    • Sydney Pharmacy School
    • Academics can be contacted directly or via media.office@sydney.edu.au
    Fields of Research (2020)
    • Work integrated learning (incl. internships)
    • Curriculum and pedagogy
    • Specialist studies in education
    • Allied health and rehabilitation science
    • Professor
    • Faculty of Medicine and Health
    • ProfessorFaculty of Medicine and Health

    MD FRACP

    Professor of Clinical Pharmacology, University of Sydney

    Visiting Professor, University of Peradeniya, Sri Lanka & Research Director, South Asian Clinical Toxicology Research Collaboration (SACTRC)

    Consultant Clinical Pharmacologist & Toxicologist, NSW Poisons Information Centre & Royal PrinceAlfred Hospital.

    Member of Editorial boards of Clinical Toxicology, Drug Safety & Australian Prescriber

    Chair of the Editorial Advisory Board of the Australian Medicines Handbook

    Chair of the Australian Therapeutic Guidelines - Toxicology and Toxinology writing group

     

    Nick Buckley is Professor of Clinical Pharmacology and a practicing clinical toxicologist consulting at RPA and through all the Poisons Centres in Australia. He is best known internationally for being a co-founder of the SACTRC collaboration, a centre of clinical toxicology research excellence in Sri Lanka with a focus on agrochemical poisoning and snakebite. http://www.sactrc.org/ Nick has been involved with contributing to the Australian Medicines Handbook since it was founded in 1998, and is now Chair of the Editorial Advisory Board. He was Deputy Editor for Clincial Toxicology from 2017-2025. He was a founding Member of the Australian Advisory Committee on the Safety of Medicines (ACSOM). He is a past President of the Asia Pacific Association of Medical Toxicology. Nick is highly experienced in clinical epidemiology and research design. His research has attracted continuous project and program funding since 2002 and has resulted in an extensive publication record including 500+ peer reviewed journal articles and 22 book chapters. He has supervised or co-supervised over 25 higher degree students.

    MD FRACP

    Professor of Clinical Pharmacology, University of Sydney

    Visiting Professor, University of Peradeniya, Sri Lanka & Research Director, South Asian Clinical Toxicology Research Collaboration (SACTRC)

    Consultant Clinical Pharmacologist & Toxicologist, NSW Poisons Information Centre & Royal PrinceAlfred Hospital.

    Member of Editorial boards of Clinical Toxicology, Drug Safety & Australian Prescriber

    Chair of the Editorial Advisory Board of the Australian Medicines Handbook

    Chair of the Australian Therapeutic Guidelines - Toxicology and Toxinology writing group

     

    Nick Buckley is Professor of Clinical Pharmacology and a practicing clinical toxicologist consulting at RPA and through all the Poisons Centres in Australia. He is best known internationally for being a co-founder of the SACTRC collaboration, a centre of clinical toxicology research excellence in Sri Lanka with a focus on agrochemical poisoning and snakebite. http://www.sactrc.org/ Nick has been involved with contributing to the Australian Medicines Handbook since it was founded in 1998, and is now Chair of the Editorial Advisory Board. He was Deputy Editor for Clincial Toxicology from 2017-2025. He was a founding Member of the Australian Advisory Committee on the Safety of Medicines (ACSOM). He is a past President of the Asia Pacific Association of Medical Toxicology. Nick is highly experienced in clinical epidemiology and research design. His research has attracted continuous project and program funding since 2002 and has resulted in an extensive publication record including 500+ peer reviewed journal articles and 22 book chapters. He has supervised or co-supervised over 25 higher degree students.

    • Sydney Pharmacy School
    • Research supervision
    • Academics can be contacted directly or via media.office@sydney.edu.au
    Fields of Research (2020)
    • Clinical pharmacology and therapeutics
    • Nephrology and urology
    • Surgery
    • Toxicology (incl. clinical toxicology)
    • Basic pharmacology
    • Pharmacology and pharmaceutical sciences
    • Clinical sciences
    • Clinical pharmacy and pharmacy practice
    • Lecturer in Pharmacy
    • Faculty of Medicine and Health
    • Lecturer in PharmacyFaculty of Medicine and Health

    Dr Alexander Burke is a proud Wiradjuri/Dharug man and registered pharmacist. He is currently working as a Lecturer (Identified) at the Sydney School of Pharmacy where he was awarded his PhD in “Training Pharmacists in providing cultural safety for Aboriginal and Torres Strait Islander Australians”. 

    Dr Alexander Burke is a proud Wiradjuri/Dharug man and registered pharmacist. He is currently working as a Lecturer (Identified) at the Sydney School of Pharmacy where he was awarded his PhD in “Training Pharmacists in providing cultural safety for Aboriginal and Torres Strait Islander Australians”. 

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Public health
    • Curriculum and pedagogy
    • NHMRC Emerging Leadership Fellow
    • Faculty of Medicine and Health
    • NHMRC Emerging Leadership FellowFaculty of Medicine and Health

    Rose Cairns (BPharm, PhD) is an Associate Professor at The University of Sydney. She has a clinical role as Senior Poisons Specialist (Research and Audit) at the New South Wales Poisons Information Centre, The Children’s Hospital at Westmead. Her research interests include clinical toxicology, pharmacovigilance, toxicovigilance, severe adverse drug reactions, substance use, medicines policy, and deliberate self-poisoning (self-harm overdose). Her overall goal is to reduce harm from poisoning.

    Rose Cairns (BPharm, PhD) is an Associate Professor at The University of Sydney. She has a clinical role as Senior Poisons Specialist (Research and Audit) at the New South Wales Poisons Information Centre, The Children’s Hospital at Westmead. Her research interests include clinical toxicology, pharmacovigilance, toxicovigilance, severe adverse drug reactions, substance use, medicines policy, and deliberate self-poisoning (self-harm overdose). Her overall goal is to reduce harm from poisoning.

    • Sydney Pharmacy School
    • Academics can be contacted directly or via media.office@sydney.edu.au
    Fields of Research (2020)
    • Toxicology (incl. clinical toxicology)
    • Public health
    • Pharmacology and pharmaceutical sciences
    • Clinical pharmacology and therapeutics
    • Clinical sciences
    • Injury prevention
    • Health services and systems
    • Director of Academic Education
    • Faculty of Medicine and Health
    • Director of Academic EducationFaculty of Medicine and Health
    BPharm MSc PhD Grad Cert Edu (Higher Ed) AACPA FPS FHEA

    Stephen is an Associate Professor in Pharmacy Practice at the University of Sydney with a specialisation in pharmacist services. He is a registered pharmacist with clinical specialisation in medication management review. Stephen's research, teaching and advocacy agenda aims to ensure that society makes greater use of pharmacists's unique skills. In regards to research, Stephen uses qualitative and quantitative methods to understand more about: a) how consumers and their caregivers obtain and use their medicines and medicines information; b) how best to design and utilise pharmacist services, both as primary care practitioners and as collaborators in teams; and c) how best to support and educate pharmacists throughout their journey from students to interns to practitioners and to on advanced practitioner status. He is a Fellow of the Pharmaceutical Society of Australia.

    Stephen's research publications have been recognised with various international awards. He is Chief Investigator on four current competitive grant funded projects worth more than $6.3m incuding co-lead of a $2.36m Randomised Controlled Trial. Stephen has international recogniiton in the field of psychometric analyses and has several method papers with high citations.

    Stephen is Program Director - Undergraduate in the Sydney Pharmacy School. He is an accedited Assessor and Mentor for the Sydney Educational fellowship for Higher Education Academy. He is a regulare reviewer for the Sydney Peer Review for Teaching Program. He is an Associate Editor of Research in Social and Administrative Pharmacy (RSAP), a Q1 journal.

    BPharm MSc PhD Grad Cert Edu (Higher Ed) AACPA FPS FHEA

    Stephen is an Associate Professor in Pharmacy Practice at the University of Sydney with a specialisation in pharmacist services. He is a registered pharmacist with clinical specialisation in medication management review. Stephen's research, teaching and advocacy agenda aims to ensure that society makes greater use of pharmacists's unique skills. In regards to research, Stephen uses qualitative and quantitative methods to understand more about: a) how consumers and their caregivers obtain and use their medicines and medicines information; b) how best to design and utilise pharmacist services, both as primary care practitioners and as collaborators in teams; and c) how best to support and educate pharmacists throughout their journey from students to interns to practitioners and to on advanced practitioner status. He is a Fellow of the Pharmaceutical Society of Australia.

    Stephen's research publications have been recognised with various international awards. He is Chief Investigator on four current competitive grant funded projects worth more than $6.3m incuding co-lead of a $2.36m Randomised Controlled Trial. Stephen has international recogniiton in the field of psychometric analyses and has several method papers with high citations.

    Stephen is Program Director - Undergraduate in the Sydney Pharmacy School. He is an accedited Assessor and Mentor for the Sydney Educational fellowship for Higher Education Academy. He is a regulare reviewer for the Sydney Peer Review for Teaching Program. He is an Associate Editor of Research in Social and Administrative Pharmacy (RSAP), a Q1 journal.

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Clinical pharmacy and pharmacy practice
    • Pharmacology and pharmaceutical sciences
    • Public health
    • Dermatology
    • Health services and systems
    • Clinical sciences
    • Clinical pharmacology and therapeutics
    • Head of Pharmacy Practice & Health Services (L2 Supervisor)
    • Faculty of Medicine and Health
    • Head of Pharmacy Practice & Health Services (L2 Supervisor)Faculty of Medicine and Health

    Ronald Castelino is an Associate Professor and Head of Pharmacy Practice & Health Services Research at the School of Pharmacy, University of Sydney. He is a practising specialist renal pharmacist at Blacktown Hospital (2016-present) and has an established track record in translational research relevant to kidney medicine. He has extensive experience in conducting health services and implementation research aimed at improving medication safety and the quality use of medicines for people with kidney disease across healthcare settings.

     

    A/Prof Castelino currently serves as the pharmacy department representative on the Blacktown and Mount Druitt Hospital Research Committee (2018-present) and has previously served on the inaugural Specialist Nephrology Pharmacists Leadership Group of Advanced Pharmacy Australia (2018-2020), the peak professional body for hospital pharmacy in Australia.

     

    A/Prof Castelino completed his Bachelor of Pharmacy (2003), Masters in Pharmacy Practice (2006) from India and PhD from the University of Sydney in 2011. After the completion of his PhD, he moved to the University of Tasmania (UTAS, 2011-2016) as a Lecturer in Therapeutics at the School of Medicine. At UTAS, he was involved in teaching therapeutics to 3rd & 4th year Pharmacy students and 3rd year Medicine students. He returned to the University of Sydney as a Senior Lecturer in Pharmacology and Clinical Pharmacy in 2016. 

    Ronald Castelino is an Associate Professor and Head of Pharmacy Practice & Health Services Research at the School of Pharmacy, University of Sydney. He is a practising specialist renal pharmacist at Blacktown Hospital (2016-present) and has an established track record in translational research relevant to kidney medicine. He has extensive experience in conducting health services and implementation research aimed at improving medication safety and the quality use of medicines for people with kidney disease across healthcare settings.

     

    A/Prof Castelino currently serves as the pharmacy department representative on the Blacktown and Mount Druitt Hospital Research Committee (2018-present) and has previously served on the inaugural Specialist Nephrology Pharmacists Leadership Group of Advanced Pharmacy Australia (2018-2020), the peak professional body for hospital pharmacy in Australia.

     

    A/Prof Castelino completed his Bachelor of Pharmacy (2003), Masters in Pharmacy Practice (2006) from India and PhD from the University of Sydney in 2011. After the completion of his PhD, he moved to the University of Tasmania (UTAS, 2011-2016) as a Lecturer in Therapeutics at the School of Medicine. At UTAS, he was involved in teaching therapeutics to 3rd & 4th year Pharmacy students and 3rd year Medicine students. He returned to the University of Sydney as a Senior Lecturer in Pharmacology and Clinical Pharmacy in 2016. 

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Clinical pharmacology and therapeutics
    • Clinical sciences
    • Pharmacology and pharmaceutical sciences
    • Nephrology and urology
    • Health promotion
    • Health services and systems
    • Clinical pharmacy and pharmacy practice
    • Public health
    • Health systems
    • Intensive care
    • Head of Pharmacy Practice and Health Services
    • Faculty of Medicine and Health
    • Head of Pharmacy Practice and Health ServicesFaculty of Medicine and Health
    BPharm, Master of Health Law (MHL), PhD MPS, FFIP

    Dr Betty Chaar is a pharmacist and Associate Professor in professionalism in pharmacy. She holds a master’s degree in Health Law and her PhD is about developing moral reasoning capabilities and ethical decision-making in pharmacy practice. Betty has been working in the field of pharmacy for many years, with experience in community pharmacy ownership, hospital pharmacy, pharmaceutical industry, academia and research.

    Dr Chaar is Chair of the Human Research Ethics committee at Family Planning NSW Health (since 2014). She is past President of the Australian Association for Professional and Applied Ethics [AAPAE]; member of the Australian Pharmacy Council [APC] Examining Committee; serves on the Peer Review committee of the Pharmacy Board [AHPRA]; a Fellow of the International Federation of Pharmacy and Chair of the FIP Ethics Expert Group in addition to being a Pharmacist Peer Reviewer for the Healthcare Complaints Commission NSW Australia.

    Dr Chaar co-chaired the Global Working Group on Pharmacy Ethics and Autonomy for FIP in The Hague, and continues this work as Chair of the FIP Ethics Expert Group.

    Dr Chaar also works with NSW Health on Opioid Substitution Treatment services in pharmacy.

    She currently conducts research on a number of practice-based projects, such as patient care at end-of-life, health literacy, weight management, hospital pharmacy, direct-to-consumer advertising, the needs of patients from various ethnic backgrounds' as well as the teaching of professional ethics in pharmacy around the world.

    BPharm, Master of Health Law (MHL), PhD MPS, FFIP

    Dr Betty Chaar is a pharmacist and Associate Professor in professionalism in pharmacy. She holds a master’s degree in Health Law and her PhD is about developing moral reasoning capabilities and ethical decision-making in pharmacy practice. Betty has been working in the field of pharmacy for many years, with experience in community pharmacy ownership, hospital pharmacy, pharmaceutical industry, academia and research.

    Dr Chaar is Chair of the Human Research Ethics committee at Family Planning NSW Health (since 2014). She is past President of the Australian Association for Professional and Applied Ethics [AAPAE]; member of the Australian Pharmacy Council [APC] Examining Committee; serves on the Peer Review committee of the Pharmacy Board [AHPRA]; a Fellow of the International Federation of Pharmacy and Chair of the FIP Ethics Expert Group in addition to being a Pharmacist Peer Reviewer for the Healthcare Complaints Commission NSW Australia.

    Dr Chaar co-chaired the Global Working Group on Pharmacy Ethics and Autonomy for FIP in The Hague, and continues this work as Chair of the FIP Ethics Expert Group.

    Dr Chaar also works with NSW Health on Opioid Substitution Treatment services in pharmacy.

    She currently conducts research on a number of practice-based projects, such as patient care at end-of-life, health literacy, weight management, hospital pharmacy, direct-to-consumer advertising, the needs of patients from various ethnic backgrounds' as well as the teaching of professional ethics in pharmacy around the world.

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Clinical pharmacy and pharmacy practice
    • Clinical pharmacology and therapeutics
    • Health services and systems
    • Pharmacology and pharmaceutical sciences
    • Health and community services
    • Health counselling
    • Health care administration
    • Patient safety
    • Primary health care
    • Professor
    • Faculty of Medicine and Health
    • ProfessorFaculty of Medicine and Health

    BPharm (Medal) NDMC Taipei PhD DSc Syd

    Hak-Kim Chan, Professor in Pharmaceutics is leading the Advanced Drug Delivery Group at the Sydney Pharmacy School. He graduated from the National Defense Medical Center (BPharm, University Medal 1983), University of Sydney (PhD 1988 and DSc 2009), was a postdoc at the University of Minnesota in 1988-89 and a scientist at Genentech Inc in 1992–95.

     

    Hak-Kim Chan is a member of Sydney Infectious Diseases Institute (Sydney ID) 

     

     https://www.sydney.edu.au/infectious-diseases

    BPharm (Medal) NDMC Taipei PhD DSc Syd

    Hak-Kim Chan, Professor in Pharmaceutics is leading the Advanced Drug Delivery Group at the Sydney Pharmacy School. He graduated from the National Defense Medical Center (BPharm, University Medal 1983), University of Sydney (PhD 1988 and DSc 2009), was a postdoc at the University of Minnesota in 1988-89 and a scientist at Genentech Inc in 1992–95.

     

    Hak-Kim Chan is a member of Sydney Infectious Diseases Institute (Sydney ID) 

     

     https://www.sydney.edu.au/infectious-diseases

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Pharmacology and pharmaceutical sciences
    • Intensive care
    • Pharmacogenomics
    • Clinical pharmacology and therapeutics
    • Infectious diseases
    • Basic pharmacology
    • Pharmaceutical delivery technologies
    • Pharmaceutical sciences
    • Clinical sciences
    • Professor of Pharmacology
    • Faculty of Medicine and Health
    • Professor of PharmacologyFaculty of Medicine and Health

    PhD, SFHEA

    Kellie is a Professor in Pharmacology and is an education-focused academic with interests in designing innovative teaching approaches for health professions education. As an education researcher, her interests focus on evaluating the effectiveness and safety of such education innovations integrating new technologies, such as artificial intelligence. High level quality use of education resources are as important for student learning as quality use of medicines are to patient's health.  

     

    Kellie has a PhD in Pharmacology from University of Sydney (2004 – Investigation of relationships between hepatic drug metabolism, inflammation and cancer). She completed postdoctoral research in the field of cancer and immunology pharmacology and was involved in 3 international clinical trials investigating the regulation of inflammatory pathways regulating ovarian cancer growth and piloting new immune modulatory drug treatments for ovarian cancer at Barts Cancer Institute and Queen Mary, University of London, UK.

     

    Kellie returned to a lectureship in Pharmacology in 2008 and was awarded a Denis Wade New Investigator Award in 2009. Kellie was awarded a Cancer Institute NSW Career Development Award in 2011 and established a research focus in the clinical utilisation of inflammatory biomarkers for prognositic and predictive clincial outcomes in patients with metastatic cancer. She has led and Chaired the organisation of a multi-institution Sydney Cancer Conference in 2010. She is a current member of the Cancer Research Network and Steering Committee.

     

    Kellie has led large scale strategic initiatives for the Sydney Medical School (curriculum redevelopment of MD program, design of inter-professional education programs) and currently chairs numerous committees associated with the governance of coordinating the preclinical aspect of the MD program at University of Sydney. She is passionate about pharmacology, particularly teaching, and was recently awarded the 2020 ASCEPT Teaching Excellence Award. In 2020, she was also awarded a Senior Fellowship of the Higher Education Academy in the UK. 

     

    Kellie is currently the ASCEPT Education Forum Chair and leads multi-institutional discussions and training for pharmacology education across Australia and New Zealand. She also Co-Chairs the Australian New Zealand Prescribing Skills Assessment Committee with A/Prof Paul Chin, University of Otago. The ANZ PSA is the national level prescribing competency exam for graduating medical students. 

    PhD, SFHEA

    Kellie is a Professor in Pharmacology and is an education-focused academic with interests in designing innovative teaching approaches for health professions education. As an education researcher, her interests focus on evaluating the effectiveness and safety of such education innovations integrating new technologies, such as artificial intelligence. High level quality use of education resources are as important for student learning as quality use of medicines are to patient's health.  

     

    Kellie has a PhD in Pharmacology from University of Sydney (2004 – Investigation of relationships between hepatic drug metabolism, inflammation and cancer). She completed postdoctoral research in the field of cancer and immunology pharmacology and was involved in 3 international clinical trials investigating the regulation of inflammatory pathways regulating ovarian cancer growth and piloting new immune modulatory drug treatments for ovarian cancer at Barts Cancer Institute and Queen Mary, University of London, UK.

     

    Kellie returned to a lectureship in Pharmacology in 2008 and was awarded a Denis Wade New Investigator Award in 2009. Kellie was awarded a Cancer Institute NSW Career Development Award in 2011 and established a research focus in the clinical utilisation of inflammatory biomarkers for prognositic and predictive clincial outcomes in patients with metastatic cancer. She has led and Chaired the organisation of a multi-institution Sydney Cancer Conference in 2010. She is a current member of the Cancer Research Network and Steering Committee.

     

    Kellie has led large scale strategic initiatives for the Sydney Medical School (curriculum redevelopment of MD program, design of inter-professional education programs) and currently chairs numerous committees associated with the governance of coordinating the preclinical aspect of the MD program at University of Sydney. She is passionate about pharmacology, particularly teaching, and was recently awarded the 2020 ASCEPT Teaching Excellence Award. In 2020, she was also awarded a Senior Fellowship of the Higher Education Academy in the UK. 

     

    Kellie is currently the ASCEPT Education Forum Chair and leads multi-institutional discussions and training for pharmacology education across Australia and New Zealand. She also Co-Chairs the Australian New Zealand Prescribing Skills Assessment Committee with A/Prof Paul Chin, University of Otago. The ANZ PSA is the national level prescribing competency exam for graduating medical students. 

    • Sydney Pharmacy School
    • Career advice
    • Conference as a panellist or speaker
    • Membership of an advisory committee
    • Research collaboration
    • Mentoring
    • Industry projects
    • Research supervision
    • 4 Quality Education
    • 10 Reduced Inequalities
    • 3 Good Health and Well Being
    Fields of Research (2020)
    • Higher education
    • Educational technology and computing
    • Education assessment and evaluation
    • Clinical pharmacology and therapeutics
    • Medicine, nursing and health curriculum and pedagogy
    • Digital health
    • Professor of Medication Management
    • Faculty of Medicine and Health
    • Professor of Medication ManagementFaculty of Medicine and Health

    PhD, DipHPharm, BPharm, FPS, FANZCAP, FFIP, ARPharmS
    Professor Timothy F Chen is nationally and internationally renowned for his research in medication review and strategies to reduce medication related harm. His research has informed significant policy and practice change, through the implementation of the Commonwealth Government funded Home Medicines Review (HMR) program. 
    Professor Chen has successfully supervised 22 PhD students to completion, published extensively in pharmacy, pharmacology, education and psychiatry journals, and has received competitive research funds of >$12m as a chief investigator.
    Professor Chen is an experienced and dedicated teacher who has received Faculty, University and Australian Government awards for teaching.
    Professor Chen has served as Director of the graduate Master of Pharmacy program and Head of Pharmacy Practice and Health Services Research.
    Over his career, Professor Chen has been an invited speaker on >90 occasions in more than 30 countries.

    From 2014 to 2021, Professor Chen served as President of the Social and Administrative Pharmacy Section of the International Pharmaceutical Federation (FIP).

    PhD, DipHPharm, BPharm, FPS, FANZCAP, FFIP, ARPharmS
    Professor Timothy F Chen is nationally and internationally renowned for his research in medication review and strategies to reduce medication related harm. His research has informed significant policy and practice change, through the implementation of the Commonwealth Government funded Home Medicines Review (HMR) program. 
    Professor Chen has successfully supervised 22 PhD students to completion, published extensively in pharmacy, pharmacology, education and psychiatry journals, and has received competitive research funds of >$12m as a chief investigator.
    Professor Chen is an experienced and dedicated teacher who has received Faculty, University and Australian Government awards for teaching.
    Professor Chen has served as Director of the graduate Master of Pharmacy program and Head of Pharmacy Practice and Health Services Research.
    Over his career, Professor Chen has been an invited speaker on >90 occasions in more than 30 countries.

    From 2014 to 2021, Professor Chen served as President of the Social and Administrative Pharmacy Section of the International Pharmaceutical Federation (FIP).

    • Sydney Pharmacy School
    • Conference as a panellist or speaker
    • Membership of an advisory committee
    • Mentoring
    • Research collaboration
    • Career advice
    • Industry projects
    • Research supervision
    Fields of Research (2020)
    • Clinical pharmacy and pharmacy practice
    • Clinical pharmacology and therapeutics
    • Toxicology (incl. clinical toxicology)
    • Health services and systems
    • Aged health care
    • Pharmacology and pharmaceutical sciences
    • Mental health services
    • Primary health care
    • Health systems
    • Health counselling
    • Senior Lecturer in Pharmacy Practice
    • Faculty of Medicine and Health
    • Senior Lecturer in Pharmacy PracticeFaculty of Medicine and Health

    Dr Janet Cheung is a Senior Lecturer in Pharmacy Practice at the School of Pharmacy, University of Sydney. She is a registered pharmacist with a broad research interest in empowering patient participation in their own health care. Her expertise in sleep research spans across patient engagement, quality use of sleep medications and shared decision-making. Janet completed her doctoral training in 2016 at the School of Pharmacy. Her PhD focused on mapping out patients' decision-making processes when selecting treatment options for insomnia, integrating principles of sociology, pharmacy practice and health economics. Following from the PhD, Janet was awarded a prestigious international postdoctoral scholarship funded by the Fonds de reserche du Quebec- Nature et technologies (FRQNT) to undertake a research fellowship at the Centre d'étude des troubles du sommeil (CETS), Laval University, Quebec Canada. Through this fellowship, Janet developed a shared-decision-making framework as part of a larger pragmatic clinical trial, funded through the Canadian Institutes of Health Research, to implant insomnia services into primary care. Janet was also the recipient of the World Sleep Young Investigator Award in 2017 for her work on the longitudinal patterns of sleep medication use in a community setting. She is currently an Associate Editor for Behavioral Sleep Medicine.

    Dr Janet Cheung is a Senior Lecturer in Pharmacy Practice at the School of Pharmacy, University of Sydney. She is a registered pharmacist with a broad research interest in empowering patient participation in their own health care. Her expertise in sleep research spans across patient engagement, quality use of sleep medications and shared decision-making. Janet completed her doctoral training in 2016 at the School of Pharmacy. Her PhD focused on mapping out patients' decision-making processes when selecting treatment options for insomnia, integrating principles of sociology, pharmacy practice and health economics. Following from the PhD, Janet was awarded a prestigious international postdoctoral scholarship funded by the Fonds de reserche du Quebec- Nature et technologies (FRQNT) to undertake a research fellowship at the Centre d'étude des troubles du sommeil (CETS), Laval University, Quebec Canada. Through this fellowship, Janet developed a shared-decision-making framework as part of a larger pragmatic clinical trial, funded through the Canadian Institutes of Health Research, to implant insomnia services into primary care. Janet was also the recipient of the World Sleep Young Investigator Award in 2017 for her work on the longitudinal patterns of sleep medication use in a community setting. She is currently an Associate Editor for Behavioral Sleep Medicine.

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Clinical sciences
    • Health services and systems
    • Clinical and health psychology
    • Public health
    • Associate Professor, Pharmaceutical and Medical Device Development
    • Faculty of Medicine and Health
    • Associate Professor, Pharmaceutical and Medical Device DevelopmentFaculty of Medicine and Health

    BSc (Hons), GCULT, PhD, SFHEA, FRAPS, FMPP

    Orin is the program director for the Pharmaceutical and Medical Device Development programs, based in the Sydney Pharmacy School at the University of Sydney. She is also a regulatory affairs consultant, and an adjunct Associate Professor at UNSW Sydney. Orin was co-chair of the Cell and Gene Catalyst Expert working Group on workforce Development. She is a member of the Board of the Association of Graduate Regulatory Educators (AGRE, USA) and is on the editorial advisory committee of the Regulatory Affairs Professionals Society (RAPS, USA). Orin received the Organisation for Professionals in Regulatory Affairs (TOPRA, UK) award for excellence in regulatory education in 2017 and became a Senior Fellow of the Higher Education Academy (UK) in 2018 in recognition of her expertise in regulatory education. She was awarded a Fellow of RAPS in 2021 in recognition of her outstanding contribution to the regulatory affairs profession. She was awarded a Fellow of ARCS/LifeSciences Australia in 2025 (Fellow Medtech and Pharma Professionals). She has a BSc (Hons) degree in biochemistry and a PhD in molecular biology from the University of Sydney and a Graduate Certificate in University Learning and Teaching from UNSW Sydney. Orin conducts research in regulatory science, pharmaceutical policy, horizon scanning and capacity-building in the pharmaceutical and medical technology ecosystem.

    BSc (Hons), GCULT, PhD, SFHEA, FRAPS, FMPP

    Orin is the program director for the Pharmaceutical and Medical Device Development programs, based in the Sydney Pharmacy School at the University of Sydney. She is also a regulatory affairs consultant, and an adjunct Associate Professor at UNSW Sydney. Orin was co-chair of the Cell and Gene Catalyst Expert working Group on workforce Development. She is a member of the Board of the Association of Graduate Regulatory Educators (AGRE, USA) and is on the editorial advisory committee of the Regulatory Affairs Professionals Society (RAPS, USA). Orin received the Organisation for Professionals in Regulatory Affairs (TOPRA, UK) award for excellence in regulatory education in 2017 and became a Senior Fellow of the Higher Education Academy (UK) in 2018 in recognition of her expertise in regulatory education. She was awarded a Fellow of RAPS in 2021 in recognition of her outstanding contribution to the regulatory affairs profession. She was awarded a Fellow of ARCS/LifeSciences Australia in 2025 (Fellow Medtech and Pharma Professionals). She has a BSc (Hons) degree in biochemistry and a PhD in molecular biology from the University of Sydney and a Graduate Certificate in University Learning and Teaching from UNSW Sydney. Orin conducts research in regulatory science, pharmaceutical policy, horizon scanning and capacity-building in the pharmaceutical and medical technology ecosystem.

    • Sydney Pharmacy School
    • 3 Good Health and Well Being
    • 9 Industry, Innovation and Infrastructure
    Fields of Research (2020)
    • Pharmacology and pharmaceutical sciences
    • Curriculum and pedagogy
    • Associate Lecturer (Teaching and Research)
    • Faculty of Medicine and Health
    • Associate Lecturer (Teaching and Research)Faculty of Medicine and Health

    Dr Kellia Chiu is an Associate Lecturer with the Sydney Pharmacy School. Prior to this, Kellia was a postdoctoral research fellow in Toronto, Canada with the Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, and with the Lunenfeld-Tanenbaum Research Institute, Sinai Health System.

    Her PhD focused on exploring the development of policies affecting community pharmacy practice. She has conducted research in critical areas of health policy across both Australia and Canada, including the use and regulation of opioids for pain and substance use disorders; vaccination access through pharmacies; policy responses to the COVID-19 pandemic; and the expanding role of pharmacists in the healthcare system. Her research expertise is in health policy analysis, primarily using qualitative research involving documentary analyses, key informant interviews, and comparative approaches.

    Kellia is also a registered pharmacist and has experience working as a pharmacist-in-charge at a local community pharmacy.

    Dr Kellia Chiu is an Associate Lecturer with the Sydney Pharmacy School. Prior to this, Kellia was a postdoctoral research fellow in Toronto, Canada with the Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, and with the Lunenfeld-Tanenbaum Research Institute, Sinai Health System.

    Her PhD focused on exploring the development of policies affecting community pharmacy practice. She has conducted research in critical areas of health policy across both Australia and Canada, including the use and regulation of opioids for pain and substance use disorders; vaccination access through pharmacies; policy responses to the COVID-19 pandemic; and the expanding role of pharmacists in the healthcare system. Her research expertise is in health policy analysis, primarily using qualitative research involving documentary analyses, key informant interviews, and comparative approaches.

    Kellia is also a registered pharmacist and has experience working as a pharmacist-in-charge at a local community pharmacy.

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Pharmacology and pharmaceutical sciences
    • Health services and systems
    • Policy and administration
    • Public health
    • Health policy
    • Professor Emeritus
    • Faculty of Medicine and Health
    • Professor EmeritusFaculty of Medicine and Health

    Professor Macdonald (Mac) Christie is a neuropharmacologist, an internationally renowned electrophysiologist and expert in ion channel and synaptic physiology and pharmacology and the leading basic opioid pharmacologist in the nation. He leads a research team that studies cellular and molecular mechanisms in opioid receptor signaling in pain pathways, the biological basis of adaptations that produce chronic pain and drug dependence. Professor Christie is internationally renowned for his studies on ion channel function and neural network plasticity in nervous system disorders such as chronic pain and drug dependence. His research is fundamentally important given the increasing use of opioids to manage moderate to severe chronic pain is complicated by adverse effects such as tolerance, opioid dependence and in some cases, addiction. Misuse and/or inappropriate prescription of opioids are added problems. Increasing the understanding of mechanisms involved in the generation of chronic pain and in the analgesic and adverse effects of opioids (including why/how opioids produce withdrawal symptoms), will pave the way for developing newer therapies that divert signals toward pathways that produce pain relief but with lower rates of adverse effects. Professor Christie is a past Director (Basic Research) and Professor at the Pain Management Research Institute, Royal North Shore Hospital, past Director of Pain and Addiction Research at the Brain and Mind Research Institute and past Associate Dean Research Faculty of Medicine and Health, University of Sydney.

    Professor Macdonald (Mac) Christie is a neuropharmacologist, an internationally renowned electrophysiologist and expert in ion channel and synaptic physiology and pharmacology and the leading basic opioid pharmacologist in the nation. He leads a research team that studies cellular and molecular mechanisms in opioid receptor signaling in pain pathways, the biological basis of adaptations that produce chronic pain and drug dependence. Professor Christie is internationally renowned for his studies on ion channel function and neural network plasticity in nervous system disorders such as chronic pain and drug dependence. His research is fundamentally important given the increasing use of opioids to manage moderate to severe chronic pain is complicated by adverse effects such as tolerance, opioid dependence and in some cases, addiction. Misuse and/or inappropriate prescription of opioids are added problems. Increasing the understanding of mechanisms involved in the generation of chronic pain and in the analgesic and adverse effects of opioids (including why/how opioids produce withdrawal symptoms), will pave the way for developing newer therapies that divert signals toward pathways that produce pain relief but with lower rates of adverse effects. Professor Christie is a past Director (Basic Research) and Professor at the Pain Management Research Institute, Royal North Shore Hospital, past Director of Pain and Addiction Research at the Brain and Mind Research Institute and past Associate Dean Research Faculty of Medicine and Health, University of Sydney.

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Signal transduction
    • Basic pharmacology
    • Cellular nervous system
    • Pharmacology and pharmaceutical sciences
    • Animal physiology - systems
    • Neurosciences
    • Medicinal and biomolecular chemistry
    • Medical physiology
    • Head of Pharmaceutical Sciences (L2 Supervisor)
    • Faculty of Medicine and Health
    • Head of Pharmaceutical Sciences (L2 Supervisor)Faculty of Medicine and Health

    Professor Wojciech Chrzanowski, MSc, PhD, DSc
    Professor of Nanomedicine • Head of Pharmaceutical Sciences • President, Asian Federation for Pharmaceutical Sciences (AFPS) • Visting Professor, Uppsala University

     

    Professor Wojciech Chrzanowski is an international leader in nanomedicine, extracellular vesicles (EVs), nanosafety, biomanufacturing and bioprocessing. At the University of Sydney, he established a cutting‑edge research program on programming cells to promote functional tissue regeneration, with a major focus on producing multifunctional biologicals (including EV‑based therapeutics) for tissue repair and the treatment of rare diseases such as epidermolysis bullosa. His work also spans longevity medicine, developing therapeutics aligned with Medicine 3.0 principles to improve healthspan and extend life quality.

    A key feature of his research is the development and integration of multifunctional therapeutics with New Approach Methodologies (NAMs) to assess their safety and therapeutic efficacy. He also uses these models to study fundamental aspects of disease and treatment. He builds multi‑organ systems that replicate pathophysiology and disease states, including age‑appropriate models for investigating age‑related conditions. These advanced platforms enable precision testing of next‑generation therapeutics and personalised interventions.

    Professor Chrzanowski pioneered single‑extracellular‑vesicle characterisation using nano‑IR (AFM‑IR), enabling direct biophysical and biochemical profiling of individual vesicles and accelerating EV‑enabled diagnostics, drug delivery and therapeutics. He leads the Nanomedicine Group and the Nanomedical Innovation Research Group, and founded and heads the Nano‑Bio‑Characterisation facility, which houses unique instrumentation for EV analysis and nano‑bio interactions.

    In addition, Professor Chrzanowski develops nano-enhanced high-intensity focused ultrasound (HIFU n+) systems, which are utilised as a non-invasive medical modality to treat various conditions (such as cancer, infections, and chronic wounds), including veterinary applications, and for biomanufacturing and modification of extracellular vesicles. This unique integration of therapeutic and HIFU technology demonstrates how his work encompasses the One Health agenda, bridging human and animal health with sustainable biomedical innovation.

    Professor Wojciech Chrzanowski, MSc, PhD, DSc
    Professor of Nanomedicine • Head of Pharmaceutical Sciences • President, Asian Federation for Pharmaceutical Sciences (AFPS) • Visting Professor, Uppsala University

     

    Professor Wojciech Chrzanowski is an international leader in nanomedicine, extracellular vesicles (EVs), nanosafety, biomanufacturing and bioprocessing. At the University of Sydney, he established a cutting‑edge research program on programming cells to promote functional tissue regeneration, with a major focus on producing multifunctional biologicals (including EV‑based therapeutics) for tissue repair and the treatment of rare diseases such as epidermolysis bullosa. His work also spans longevity medicine, developing therapeutics aligned with Medicine 3.0 principles to improve healthspan and extend life quality.

    A key feature of his research is the development and integration of multifunctional therapeutics with New Approach Methodologies (NAMs) to assess their safety and therapeutic efficacy. He also uses these models to study fundamental aspects of disease and treatment. He builds multi‑organ systems that replicate pathophysiology and disease states, including age‑appropriate models for investigating age‑related conditions. These advanced platforms enable precision testing of next‑generation therapeutics and personalised interventions.

    Professor Chrzanowski pioneered single‑extracellular‑vesicle characterisation using nano‑IR (AFM‑IR), enabling direct biophysical and biochemical profiling of individual vesicles and accelerating EV‑enabled diagnostics, drug delivery and therapeutics. He leads the Nanomedicine Group and the Nanomedical Innovation Research Group, and founded and heads the Nano‑Bio‑Characterisation facility, which houses unique instrumentation for EV analysis and nano‑bio interactions.

    In addition, Professor Chrzanowski develops nano-enhanced high-intensity focused ultrasound (HIFU n+) systems, which are utilised as a non-invasive medical modality to treat various conditions (such as cancer, infections, and chronic wounds), including veterinary applications, and for biomanufacturing and modification of extracellular vesicles. This unique integration of therapeutic and HIFU technology demonstrates how his work encompasses the One Health agenda, bridging human and animal health with sustainable biomedical innovation.

    • Sydney Pharmacy School
    • Research supervision
    Fields of Research (2020)
    • Medical molecular engineering of nucleic acids and proteins
    • Biomaterials
    • Medical biotechnology
    • Mechanobiology
    • Medical biotechnology diagnostics (incl. biosensors)
    • Biomedical engineering
    • Medical devices
    • Nanomedicine
    • Regenerative medicine (incl. stem cells)
    • Nanotoxicology, health and safety
    • NHMRC Emerging Leadership Senior Research Fellow
    • Faculty of Medicine and Health
    • NHMRC Emerging Leadership Senior Research FellowFaculty of Medicine and Health

    Dr. Chua is a Senior Lecturer in Pharmacology at the University of Sydney and an NHMRC Emerging Leadership Senior Research Fellow based at the Charles Perkins Centre. His research focuses on ion channel structure, function and their roles in diseases. Dr. Chua has developed and patented functional assays for drug discovery and has published work on the sodium leak channel (NALCN) and voltage-gated sodium channels (classical and atypical). He is passionate about translating mechanistic insights into improved diagnosis and therapeutic strategies for different channelopathies.

     

    Enquiries from motivated Honours, Master's, and PhD students interested are welcomed. Please get in touch via email to discuss available projects.

    Dr. Chua is a Senior Lecturer in Pharmacology at the University of Sydney and an NHMRC Emerging Leadership Senior Research Fellow based at the Charles Perkins Centre. His research focuses on ion channel structure, function and their roles in diseases. Dr. Chua has developed and patented functional assays for drug discovery and has published work on the sodium leak channel (NALCN) and voltage-gated sodium channels (classical and atypical). He is passionate about translating mechanistic insights into improved diagnosis and therapeutic strategies for different channelopathies.

     

    Enquiries from motivated Honours, Master's, and PhD students interested are welcomed. Please get in touch via email to discuss available projects.

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Basic pharmacology
    • Biologically active molecules
    • Medical physiology
    • Biochemistry and cell biology
    • Neurosciences
    • Medical biochemistry and metabolomics
    • Cell neurochemistry
    • Receptors and membrane biology
    • Neurology and neuromuscular diseases
    • Medical genetics (excl. cancer genetics)
    • Lecturer
    • Faculty of Medicine and Health
    • LecturerFaculty of Medicine and Health

    Simmie Chung, a Lecturer at Sydney Pharmacy School (SPS), is known for her empathetic and pastoral approach to student support. As the Program Director of the national NAPE Intern Training Program, she contributes to mentoring and shaping the professional pathways of pre-registrant pharmacists. With nearly 30 years of experience as a registered pharmacist, particularly in oncology and production pharmacy, she aims to inspire and foster resilience among future health leaders.

    Her curriculum innovations focus on technological proficiency, critical thinking and ethical awareness, preparing students to tackle Australia's complex health challenges. Her research focuses on pharmacist's role in lung cancer, with broader interests in enhancing resilience and empathy through teaching and learning practices. Recognised for her contributions to education and mentorship, along with her student-centred approach, Simmie has received the Outstanding Teaching Excellence Individual Award (FMH, Makers and Shapers Awards) and was nominated for Dr Erica Sainsbury Pharmacist Supervisor Award. She has been awarded the Senior Fellow with the Higher Education Academy UK (now part of Advance HE) for her ability to lead, influence, and mentor others within higher education.

    Simmie's extensive experience spans across academic teaching, community practice, hospital settings, and the pharmaceutical industry. Her teaching philosophy aims to enhance students' professional developmental trajectories, emphasising the progression from clinical knowledge to clinical competence. She actively involves in improving professional practice, promoting continuous education, and strengthening the pharmacist's role in the primary care setting. Her efforts are evidenced by consistent positive feedback and high scores in Unit of Studies Survey, further highlighted by her feature in the FMH September News as a high-scoring Unit of Study Coordinator (2024).

    Simmie Chung, a Lecturer at Sydney Pharmacy School (SPS), is known for her empathetic and pastoral approach to student support. As the Program Director of the national NAPE Intern Training Program, she contributes to mentoring and shaping the professional pathways of pre-registrant pharmacists. With nearly 30 years of experience as a registered pharmacist, particularly in oncology and production pharmacy, she aims to inspire and foster resilience among future health leaders.

    Her curriculum innovations focus on technological proficiency, critical thinking and ethical awareness, preparing students to tackle Australia's complex health challenges. Her research focuses on pharmacist's role in lung cancer, with broader interests in enhancing resilience and empathy through teaching and learning practices. Recognised for her contributions to education and mentorship, along with her student-centred approach, Simmie has received the Outstanding Teaching Excellence Individual Award (FMH, Makers and Shapers Awards) and was nominated for Dr Erica Sainsbury Pharmacist Supervisor Award. She has been awarded the Senior Fellow with the Higher Education Academy UK (now part of Advance HE) for her ability to lead, influence, and mentor others within higher education.

    Simmie's extensive experience spans across academic teaching, community practice, hospital settings, and the pharmaceutical industry. Her teaching philosophy aims to enhance students' professional developmental trajectories, emphasising the progression from clinical knowledge to clinical competence. She actively involves in improving professional practice, promoting continuous education, and strengthening the pharmacist's role in the primary care setting. Her efforts are evidenced by consistent positive feedback and high scores in Unit of Studies Survey, further highlighted by her feature in the FMH September News as a high-scoring Unit of Study Coordinator (2024).

    • Sydney Pharmacy School
    Fields of Research (2020)
    • Curriculum and pedagogy